Work

Identification of the First trans-(3R,4R)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity

Year: 2001

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm015521r

Authors: James B. Thomas, Robert N. Atkinson, Richard B. Rothman, Scott E. Fix, S. Wayne Mascarella, N. Ariane Vinson, Heng Xu, Christina M. Dersch, Y. -F. Lu, Buddy E. Cantrell, Dennis M. Zimmerman, F. Ivy Carroll

Institutions: National Institutes of Health, National Institute on Drug Abuse, Eli Lilly (United States), RTI International

Language: English

Topic: Neuropeptides and Animal Physiology

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Drug Abuse

Awards: G3861717303, Selective Opioid Antagonists as Medications for Drug Abuse

OpenAlex ID: W2056132478

FWCI: 0.736

Cites: 10

Cited by: 108

Related to: 10